Related Experiment Video
Updated: May 15, 2026
10:28
Using Synthetic Biology to Engineer Living Cells That Interface with Programmable Materials
Published on: March 9, 2017
Combinational biosynthesis of phycocyanobilin using genetically-engineered Escherichia coli
Baosheng Ge1, Yan Li, Haixiang Sun
1Center for Bioengineering and Biotechnology, China University of Petroleum (East China), Qingdao 266580, People's Republic of China.
Biotechnology Letters
|January 12, 2013
Summary
Scientists engineered E. coli to produce phycocyanobilin (PCB) using heme. Optimized conditions yielded 3 mg/l, and purification achieved >95% pure PCB, demonstrating its potent antioxidant capabilities.
Area of Science:
- Biotechnology
- Biochemistry
- Metabolic Engineering
Background:
- Phycocyanobilin (PCB) is a vital pigment with antioxidant properties.
- Efficient production of PCB is crucial for its applications.
- Current methods for PCB production may be limited.
Purpose of the Study:
- To develop a recombinant microbial system for phycocyanobilin (PCB) production.
- To optimize culture conditions for maximizing PCB yield.
- To establish a purification protocol for high-purity recombinant PCB.
Main Methods:
- Cloning and combinatorial expression of key PCB biosynthesis genes in E. coli.
- Optimization of fermentation conditions to enhance PCB production.
- Development of a purification strategy involving solvent extraction and chromatography.
Main Results:
- Achieved approximately 3 mg/l of PCB under optimized culture conditions.
- Established a purification protocol yielding >95% pure PCB.
- Demonstrated that recombinant PCB effectively scavenges hydroxyl radicals with an EC50 of 0.1 μM.
Conclusions:
- Recombinant E. coli can be engineered for efficient phycocyanobilin production.
- Optimized fermentation and purification protocols enable high-purity PCB recovery.
- Recombinant PCB exhibits significant antioxidant activity, suggesting therapeutic potential.
More Related Videos
Related Concept Videos
01:24Biosynthesis in Bacteria
Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
01:22Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...